Cargando…

The Association of Diabetes Mellitus with Clinical Outcomes after Coronary Stenting: A Meta-Analysis

BACKGROUND: Previous studies have shown inconsistent results on the association between diabetes mellitus (DM) and some clinical outcomes. We conducted a meta-analysis of observational studies to assess effect of DM on clinical outcomes after coronary stenting. METHODS: We searched for studies witho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Shan-Yu, Zhou, You, Jiang, Hai-Xing, Hu, Bang-Li, Tao, Lin, Xie, Min-zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774683/ https://www.ncbi.nlm.nih.gov/pubmed/24066025 http://dx.doi.org/10.1371/journal.pone.0072710

Ejemplares similares

Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis
por: Hu, Rui-ting, et al.
Publicado: (2015)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

The Impact of Diabetes Mellitus on Clinical Outcomes after Percutaneous Coronary Intervention with Different Stent Sizes
por: Zibaeenezhad, Mohammad Javad, et al.
Publicado: (2022)

Association of Helicobacter pylori with Elevated Blood Ammonia Levels in Cirrhotic Patients: A Meta-Analysis
por: Jiang, Hai-Xing, et al.
Publicado: (2013)

Impact of Diabetes Mellitus on Early Clinical Outcome and Stent Restenosis after Carotid Artery Stenting
por: Achim, Alexandru, et al.
Publicado: (2022)

Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Chun, Kyeong-Hyeon, et al.
Publicado: (2017)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention
por: Hu, Cheng-Ping, et al.
Publicado: (2018)

One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis
por: Wang, Hong, et al.
Publicado: (2022)

Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Li, Suiping, et al.
Publicado: (2021)

Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis
por: Zhao, Lin, et al.
Publicado: (2017)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2015)

Long‐Term (10‐Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus
por: Lee, Kyusup, et al.
Publicado: (2020)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
por: Paramasivam, Ganesh, et al.
Publicado: (2020)

Long-term outcome after coronary stenting
por: Kastrati, Adnan, et al.
Publicado: (2000)

Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus
por: Wang, Hao-Yu, et al.
Publicado: (2020)

Risk of type 2 diabetes mellitus after gestational diabetes mellitus: A systematic review & meta-analysis
por: You, Huaxuan, et al.
Publicado: (2021)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Serial coronary computed tomography angiography-verified coronary plaque progression: comparison of stented patients with or without diabetes
por: Shi, Rui, et al.
Publicado: (2019)

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial
por: Romaguera, Rafael, et al.
Publicado: (2021)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Impact of Coronary Stent Architecture on Clinical Outcomes: Do Minor Changes in Stent Architecture Really Matter?
por: Nuruddin, Amin Ariff Bin, et al.
Publicado: (2020)

Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18–45 Years with Diabetes Mellitus
por: Li, Yang, et al.
Publicado: (2017)

Comparing mortality and myocardial infarction between coronary artery bypass grafting and drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis
por: Qi, Xiaolong, et al.
Publicado: (2014)

In-Hospital Outcome of Patients with Diabetes Mellitus after CTO Recanalization with Third-Generation Drug-Eluting Stents
por: Guelker, Jan-Erik, et al.
Publicado: (2019)

Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis
por: Wang, Hong, et al.
Publicado: (2023)

Diabetes mellitus: a prothrombotic state Implications for outcomes after coronary revascularization
por: Cola, Clarissa, et al.
Publicado: (2009)

Impact of Diabetes Mellitus on Outcomes after High-Risk Interventional Coronary Procedures
por: Johannsen, Laura, et al.
Publicado: (2020)

Ten‐year Outcomes After Drug‐Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow‐Up Study
por: Jeong, Yeong Jin, et al.
Publicado: (2021)

Sex difference in clinical outcomes of Chinese patients with atrial fibrillation and coronary stenting according to age
por: Zheng, Jian-Yong, et al.
Publicado: (2020)

Predictive value of neutrophil-to-lymphocyte ratio on drug eluting stent restenosis in patients with type 2 diabetes mellitus
por: Wang, Zhi-Chao, et al.
Publicado: (2020)

Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis
por: Jiang, Zhi-Ming, et al.
Publicado: (2022)

Are Everolimus-Eluting Stents Associated With Better Clinical Outcomes Compared to Other Drug-Eluting Stents in Patients With Type 2 Diabetes Mellitus?: A Systematic Review and Meta-Analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up
por: Cheng, Gong, et al.
Publicado: (2019)

Cardiovascular outcomes associated with Ultrathin bioresorbable polymer sirolimus eluting stents versus thin, durable polymer everolimus eluting stents following percutaneous coronary intervention in patients with type 2 diabetes mellitus: A meta-analysis of published studies
por: Deng, Shibing, et al.
Publicado: (2020)

Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis
por: Meng, Min, et al.
Publicado: (2016)

Long term outcomes of drug-eluting stent versus coronary artery bypass grafting for left main coronary artery disease: a meta-analysis
por: Cui, Kong-Yong, et al.
Publicado: (2018)

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus: Cumulative meta‐analysis
por: Xie, Qiuping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01re4malvv9lruc235j48vk4k2